RFK Jr.’s FDA expected to lift restrictions on risky, unproven peptides

Robert F. Kennedy Jr., the controversial Health Secretary known for his anti-vaccine stance, is advocating for the Food and Drug Administration (FDA) to ease restrictions on a range of injectable peptide therapies. These treatments, which have minimal efficacy data available, were previously deemed unsafe by the FDA and are now under scrutiny for their potential health risks. Kennedy has openly expressed his support for these unverified treatments, referring to himself as a 'big fan.' Peptides are essentially chains of amino acids that can influence numerous biological functions. While there are FDA-approved peptide medications like GLP-1s for weight management and insulin for diabetes, many online peptide products lack regulatory approval. They have gained traction among wellness advocates, celebrities, and self-described 'biohackers' who make bold claims about their ability to treat various ailments, rejuvenate the body, and enhance physical appearance without scientific backing. During a recent appearance on Joe Rogan’s podcast, Kennedy discussed his personal experiences using these unproven peptides, claiming significant benefits in treating injuries. He pledged to put an end to what he describes as the FDA's 'war on peptides' and outlined his strategy to reverse the agency's restrictions on several of these treatments. This movement comes in light of the FDA's 2023 decision to reclassify many unproven peptide drugs, citing serious safety concerns amidst a surge in unfounded claims regarding their effectiveness. This reclassification removed these peptides from the list of medications that compounding pharmacies can produce, limiting their availability for patient use. Despite this, a thriving black and gray market continues to offer these dubious peptide products, with some being sold for 'research use' while others are completely illicit. Interestingly, some of Kennedy's supporters are reportedly involved in selling these unverified peptide treatments.